Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 06, 2020

SELL
$16.46 - $27.42 $938,549 - $1.56 Million
-57,020 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$14.46 - $21.8 $12,001 - $18,094
830 Added 1.48%
57,020 $982,000
Q4 2019

Feb 03, 2020

BUY
$15.15 - $18.89 $9,393 - $11,711
620 Added 1.12%
56,190 $990,000
Q3 2019

Oct 29, 2019

BUY
$17.68 - $22.65 $1,414 - $1,812
80 Added 0.14%
55,570 $983,000
Q2 2019

Jul 31, 2019

BUY
$18.93 - $24.75 $11,358 - $14,850
600 Added 1.09%
55,490 $1.19 Million
Q1 2019

May 15, 2019

SELL
$19.6 - $24.76 $328,104 - $414,482
-16,740 Reduced 23.37%
54,890 $1.31 Million
Q4 2018

Feb 14, 2019

BUY
$13.65 - $21.8 $977,749 - $1.56 Million
71,630 New
71,630 $1.41 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Municipal Employees' Retirement System Of Michigan Portfolio

Follow Municipal Employees' Retirement System Of Michigan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Municipal Employees' Retirement System Of Michigan, based on Form 13F filings with the SEC.

News

Stay updated on Municipal Employees' Retirement System Of Michigan with notifications on news.